Mesenchymal stem cell exosomes

被引:459
作者
Lai, Ruenn Chai [1 ]
Yeo, Ronne Wee Yeh [1 ]
Lim, Sai Kiang [1 ,2 ]
机构
[1] Agcy Sci Technol & Res, Inst Med Biol, Singapore, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore
关键词
Mesenchymal stem cell; Exosome; Homeostasis; MARROW STROMAL CELLS; IMPROVE CARDIAC-FUNCTION; SUPPRESS T-LYMPHOCYTE; VERSUS-HOST-DISEASE; IN-VITRO; MEDIATED ACTIVATION; REPERFUSION INJURY; ESCHERICHIA-COLI; PROGENITOR CELLS; CLINICAL-TRIALS;
D O I
10.1016/j.semcdb.2015.03.001
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
MSCs are an extensively used cell type in clinical trials today. The initial rationale for their clinical testing was based on their differentiation potential. However, the lack of correlation between functional improvement and cell engraftment or differentiation at the site of injury has led to the proposal that MSCs exert their effects not through their differentiation potential but through their secreted product, more specifically, exosomes, a type of extracellular vesicle. We propose here that MSC exosomes function as an extension of MSC's biological role as tissue stromal support cells. Like their cell source, MSC exosomes help maintain tissue homeostasis for optimal tissue function. They target housekeeping biological processes that operate ubiquitously in all tissues and are critical in maintaining tissue homeostasis, enabling cells to recover critical cellular functions and begin repair and regeneration. This hypothesis provides a rationale for the therapeutic efficacy of MSCs and their secreted exosomes in a wide spectrum of diseases. Here, we give a brief introduction of the biogenesis of MSC exosomes, review their physiological functions and highlight some of their biochemical potential to illustrate how MSC exosomes could restore tissue homeostasis leading to tissue recovery and repair. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 133 条
[91]
Multilineage potential of adult human mesenchymal stem cells [J].
Pittenger, MF ;
Mackay, AM ;
Beck, SC ;
Jaiswal, RK ;
Douglas, R ;
Mosca, JD ;
Moorman, MA ;
Simonetti, DW ;
Craig, S ;
Marshak, DR .
SCIENCE, 1999, 284 (5411) :143-147
[92]
Prions and exosomes:: From PrPc trafficking to PrPsc propagation [J].
Porto-Carreiro, I ;
Février, B ;
Paquet, S ;
Vilette, D ;
Raposo, G .
BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (02) :143-148
[93]
Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens [J].
Potian, JA ;
Aviv, H ;
Ponzio, NM ;
Harrison, JS ;
Rameshwar, P .
JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3426-3434
[94]
Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche [J].
Raffaghello, Lizzia ;
Bianchi, Giordano ;
Bertolotto, Maria ;
Montecucco, Fabrizio ;
Busca, Alessandro ;
Dallegri, Franco ;
Ottonello, Luciano ;
Pistoia, Vito .
STEM CELLS, 2008, 26 (01) :151-162
[95]
Alzheimer's disease β-amyloid peptides are released in association with exosomes [J].
Rajendran, Lawrence ;
Honsho, Masanori ;
Zahn, Tobias R. ;
Keller, Patrick ;
Geiger, Kathrin D. ;
Verkade, Paul ;
Simons, Kai .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (30) :11172-11177
[96]
B lymphocytes secrete antigen-presenting vesicles [J].
Raposo, G ;
Nijman, HW ;
Stoorvogel, W ;
Leijendekker, R ;
Harding, CV ;
Melief, CJM ;
Geuze, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1161-1172
[97]
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells [J].
Rasmusson, I ;
Ringdén, O ;
Sundberg, B ;
Le Blanc, K .
TRANSPLANTATION, 2003, 76 (08) :1208-1213
[98]
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms [J].
Rasmusson, I ;
Ringdén, O ;
Sundberg, B ;
Le Blanc, K .
EXPERIMENTAL CELL RESEARCH, 2005, 305 (01) :33-41
[99]
Ren G, 2009, STEM CELLS, V27, P1954
[100]
Cardiac Metabolism in Myocardial Ischemia [J].
Rosano, Giuseppe M. C. ;
Fini, Massimo ;
Caminiti, Giuseppe ;
Barbaro, Giuseppe .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (25) :2551-2562